SENSEX 82095.48 (0.80)
Nifty 50 24984.25 (0.94)
Nifty Bank 56543.95 (1.40)
Nifty IT 37138.6 (0.08)
Nifty Midcap 100 58701.25 (0.68)
Nifty Next 50 67682.8 (0.80)
Nifty Pharma 21587.9 (-0.26)
Nifty Smallcap 100 18506.25 (0.40)
NIKKEI 225 37687.94 (0.36)
HANG SENG 23807 (-0.42)
S&P 5979.25 (0.36)
BSE Code : 524404 | NSE Symbol : MARKSANS | ISIN : INE750C01026 | Industry : Pharmaceuticals |
Hot Pursuit 30-May-2025 (09:33) Marksans Pharma gets regulatory nod for marketing type-2 diabetes medication in UK
Corporate News 30-May-2025 (09:13) Relonchem receives marketing authorization for Metformin Hydrochloride 500mg/ 5 ml Oral Solution in UK
Corporate News 20-May-2025 (12:49) Board of Marksans Pharma recommends final dividend
Results 20-May-2025 (07:46) Marksans Pharma consolidated net profit rises 15.66% in the March 2025 quarter
Corporate News 19-May-2025 (13:29) Relonchem receives marketing authorization for Sennosides 7.5 mg tablets
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others